Markintel™ Pulse Report – August 2025
The Europe – AI‑assisted Medical Imaging Pulse report sizes and forecasts AI spend across CT, MRI, X‑ray/DR, Ultrasound, and PET/Nuclear for DE, FR, UK, IT, ES, RoE. It provides 2023–24 actuals and a 2025–2032 forecasts by modality, clinical area, application, revenue stream, end‑use organization, and AI technology—plus GTM Growth & Maturity, Ecosystem Collaboration, and Solution Adoption & Growth frameworks tailored to Europe.
This 88‑page Markintel™ Pulse report from Marketstrat™ delivers a Europe‑only view of AI in medical imaging. Regional frameworks—GTM Growth & Maturity (vendor view), Ecosystem Collaboration Matrix, and Solution Adoption & Growth—translate evidence into sequencing, partnering, and pricing decisions. Country chapters for Germany, France, the UK, Italy, Spain, and RoE include GTM readiness, pricing fit, and tiered customer landscapes. Methodology reconciles a top‑down Europe spend model with bottom‑up attach‑rate × ASP engines by modality and country, weighted by regulatory filings, audited financials, licensed expert transcripts, and RWE.
Europe – AI‑assisted Medical Imaging (Markintel™ Pulse) delivers a focused 88‑page forecast across CT, MRI, X‑ray/DR, Ultrasound and PET/Nuclear for Germany, France, the UK, Italy, Spain and Rest of Europe. It includes 2023–24 actuals and a 2025–2032 outlook by clinical area, application, revenue stream and end‑use. Key numbers: US $ 680 M (2023) → US $ 6.40 B (2032) at 28.3 % CAGR; fastest growth in MRI, Ultrasound, Cloud/Pay‑per‑Use and teleradiology. Regional frameworks—GTM Growth & Maturity, Ecosystem Collaboration, Solution Adoption & Growth.
Country reality: Germany pivots to modular SaaS by 2027; UK favors cloud/usage pricing; France prioritizes integration & compliance; Italy grows MR‑led AI via PNRR; Spain’s case is backlog reduction; RoE clusters show strong retrofit potential.
Decision‑ready frameworks: GTM Growth & Maturity, Ecosystem Collaboration, Solution Adoption & Growth—all Europe‑level.
Market Snapshot
Competitve Landscape
Europe’s competitive field is bifurcating:
Vendors that couple MDR‑ready portfolios with retrofit‑friendly pricing and marketplace reach will capture the lion’s share of Europe’s projected US $ 6.4 B imaging‑AI spend by 2032.
Europe’s adoption is rigorous but consistent. By 2032, the projected $6 B+ market is feasible, with major expansions after ~2026 once more AI solutions re-certify under the new MDR and intangible acceptance climbs. Radiology leadership expects AI to become a “must-have,” especially for screening programs and time-critical diagnoses, across the continent.
Siemens (3 new CE/MDR grants) and GE (2) led the 2023-24 filing sprint, while Philips and two pure plays (Lunit, Viz.ai) each logged two approvals. The median pure play managed only one new clearance, indicating that MDR’s documentation load is widening the gap between well-capitalized vendors and small start-ups.
1. Hospitals: still the anchor, share drifts lower
2. Imaging Centers: fastest cap‑ex recyclers
3. Teleradiology: breakout growth winner
4. Clinics & Specialists: steady but secondary
5. “Other” Institutions
Pricing agility and regulatory readiness dominate: disparate GDP‑per‑capita and mixed GDPR/Swiss‑FADP rules require tiered price menus and meticulous compliance. Partnerships with EU hubs and marketplace channels follow. Demand‑gen is least critical—local pilots trump broad marketing. Vendors must budget for multi‑currency SaaS quoting and Notified‑Body engagement before scaling.
SECTION 1 | EXECUTIVE SUMMARY
What this Pulse Covers
Key Numbers Snapshot (Europe)
What’s Driving Europe’s Curve
Where the Value Pools Form
Country Outlook—Six Different Routes to Scale
Near‑term Watchlist (Next 12–18 Months)
What to do now (Insights → Action)
OEMs
Pure‑plays
Providers & Networks
Investors
SECTION 2 | RESEARCH METHODOLOGY
About this Pulse Report
Scope & Segmentation
Marketstrat’s “Insights → Action” Approach
Dual‑lens Architecture
Top‑down Market Funnel (Europe)
How it Works in the Model
Bottom‑up Attach‑rate Flow (Europe)
What we model for Each Country and Segment
Evidence Confidence — Density vs Reliability (Europe)
Reading the Bubbles
Regional Frameworks Included in this Pulse Report
GTM Country Tools
Quality Assurance & Governance
Limitations & Mitigations
SECTION 3 | EUROPEAN MARKET ANALYSIS
Market Overview & Analysis
Market Snapshot
Structural Demand Signals
Regulatory & Funding Landscape (2024-2028)
Market Segmentation 2032 (value share)
Competitive Heat Map (2024-26)
Execution Playbook (2024-2027)
Action-Oriented Recommendations
European Market Estimates and Forecasts by Country (2023-2032, USD Mill)
Five Forces Shaping Adoption
Country Archetypes & What Sells
Near‑term Adoption Runway (2024-27)
Strategic Implications
Regulatory Velocity by Company – Europe
Markintel Growth Maturity Matrix – Europe
Landscape Snapshot
Why the Quadrant Looks the Way it Does
Key Competitive Dynamics
Strategic Takeaways
Bottom Line
M&A Watchlist – Europe
Competitive Dataset – Europe
Growth & Maturity Highlights – Europe
Markintel Ecosystem Collaboration Matrix (ECM) – Europe
Quadrant Commentary & European Illustrations
Action Checklist
Markintel Solution Adoption & Growth Matrix – Europe
Quadrant Deep Dive
What Moves a Solution from One Box to the Next?
Strategic Guidance
AI Attach Rate – Europe
OEM AI Attach Rate
Attach Rate Trends – Europe
AI Revenue Split – Factory vs Retrofit Attach — Europe
GTM at a Glance – Europe
Channel & Pricing Matrix (2025-2028)
GTM Readiness Radar — Europe
Tiered Customer Landscape (2032 View)
GTM Timeline (2025 → 2028) – Europe
Adjacency Opportunity Radar (2026+) – Europe
Regulatory x Funding Heatmap – Europe
AI Imaging Whitespace Matrix – Europe
Fast Strategic Cues (2025 playbook)
SECTION 4 | GERMAN MARKET
Market Overview – Germany
Macro & Epidemiology
Health‑system & Funding Landscape
Regulatory & Evidence Pathway
Competitive Landscape
Strategic Takeaways & Recommendations
German Market by Clinical Area
Forecast by Clinical Area (2023-2032, USD Mill)
Primary Growth Catalysts
Strategic Messages for Stakeholders
Key Takeaways
German Market by Modality (2023-2032, USD Million)
Forecast by Modality (2023-2032, USD Mill)
Key Inflection by Modality
What’s Driving Each Modality
Strategic Implications
German Market by Revenue Stream (2023-2032, USD Million)
Forecast by Revenue Stream (2023-2032, USD Mill)
Revenue Streams and Drivers
Key Dynamics by Stream
Strategic Guidance
German Market by Clinical Application (2023-2032, USD Million)
Forecast by Clinical Application (2023-2032, USD Mill)
What is Driving Each Bucket
Strategic Messages
Action Playbook
German Market by End-Use Organization (2023-2032, USD Million)
Forecast by End-Use Organization (2023-2032, USD Mill)
Segments Review
Strategic Implications
German Market by AI Technology (2023-2032, USD Million)
Forecast by AI Technology (2023-2032, USD Mill)
Germany – AI Imaging Market by Core Technology
Why Deep Learning Keeps the Lion’s Share
Break-out Growth Themes
Strategic Playbook
GTM at-a-Glance – Germany
Channel x Pricing Matrix
GTM Readiness Radar — Germany
Tiered Customer Landscape
GTM Timeline – Germany
Fast Strategic Cues
SECTION 5 | FRENCH MARKET
Market Summary: France
Top‑line Snapshot – France
Key Market Dynamics
Strategic Takeaways
Top 3 Recommendations
French Market Speed scan – Market Analysis (2024‑2032)
French Market Estimates and Forecasts (2023-2032)
French Market by Clinical Area (2023-2032)
French Market by Modality (2023-2032)
French Market by Revenue Stream (2023-2032)
French Market by Clinical Application (2023-2032)
French Market by End-Use Organization (2023-2032)
French Market by AI Technology (2023-2032)
GTM at a Glance – France
Channel x Pricing Matrix
GTM Readiness Radar — What Counts Most in France
GTM Timeline (2024‑30) – France
Spend Potential by Customer Tier – France
SECTION 6 | UNITED KINGDOM MARKET
Market Overview – United Kingdom
UK Market Speed Scan
Scale & growth
Policy & funding
Demand triggers
Procurement routes
Competitive Field
Winning playbook 2024‑27
UK Market Estimates and Forecasts (2023-2032)
UK Market by Clinical Area (2023-2032)
UK Market by Modality (2023-2032)
UK Market by Revenue Stream (2023-2032)
UK Market by Clinical Application (2023-2032)
UK Market by End-Use Organization (2023-2032)
UK Market by AI Technology (2023-2032)
GTM at a Glance – UK
Channel x Pricing Matrix
GTM Readiness Radar – UK
Fast Strategic Cues
Tiered Customer Landscape – UK
GTM Timeline (2024‑29) – UK
SECTION 7 | ITALIAN MARKET
Market Overview & Summary: Italy
What Makes Italy Unique in the EU Context
Strategic Takeaways
Italian Market Estimates & Forecasts (2023-2032)
Italian Market by Clinical Area (2023-2032)
Italian by Modality (2023-2032)
Italian Market by Revenue Stream (2023-2032)
Italian Market by Clinical Application (2023-2032)
Italian Market by End-Use Organization (2023-2032)
Italian Market by AI Technology (2023-2032)
GTM at a Glance – Italy
Channel × Pricing Matrix
Tiered Customer Landscape & Spend Potential (2032) – Italy
GTM Readiness Radar – Italy
GTM Timeline (2024-29) – Italy
Fast Strategic Cues
SECTION 8 | SPANISH MARKET
Market Overview & Summary – Spain
Strategic Takeaways
Spanish Market Estimates and Forecasts (2023-2032)
Spanish Market by Clinical Area (2023-2032)
Spanish Market by Modality (2023-2032)
Spanish Market by Clinical Application (2023-2032)
Spanish Market by Revenue Stream (2023-2032)
Spanish Market by End-Use Organization (2023-2032)
Spanish Market by AI Technology (2023-2032)
GTM at a Glance – Spain
GTM Readiness Radar – Spain
Channel x Pricing Matrix
Tiered Customer Landscape – Spain
GTM Timeline – Spain
SECTION 9 |REST OF EUROPE (ROE) MARKET
Market Overview: Rest of Europe (ROE)
Size & trajectory
Why Growth Accelerates
Risks / Headwinds
Strategic Takeaways
Rest of European Market for AI in Medical Imaging (2023-2032)
Rest of European Market by Clinical Area (2023-2032)
Rest of European Market by Modality (2023-2032)
Rest of European Market by Revenue Stream (2023-2032)
Rest of European Market by Clinical Application (2023-2032)
Rest of European Market by End-Use Organization (2023-2032)
Rest of European Market by AI Technology (2023-2032)
GTM at a Glance – Rest of Europe (ROE)
GTM Readiness Radar – ROE
Tiered Customer Landscape – ROE
GTM Timeline – ROE
Channel × Pricing Matrix
Adjacency-Opportunity Matrix (2026-2030)
Country‑Cluster Framework & Strategic Playbook
White-Space Partnership Matrix
Regulatory Funding Heatmap (ROE Clusters)
Fast Strategic Cues
List of Tables
Table 1: AI Imaging Market by Country – Europe (2023—2032, USD Mill)
Table 2: German Market for AI in Medical Imaging by Clinical Area (2023-2032, USD Million)
Table 3: German Market for AI in Medical Imaging by Modality (2023-2032, USD Million)
Table 4: German Market for AI in Medical Imaging by Revenue Stream (2023-2032, USD Million)
Table 5: German Market for AI in Medical Imaging by Clinical Application (2023-2032, USD Million)
Table 6: German Market for AI in Medical Imaging by End-Use Organization (2023-2032, USD Million)
Table 7: German Market for AI in Medical Imaging by AI Technology (2023-2032, USD Million)
Table 8: French Market for AI in Medical Imaging by Clinical Area (2023-2032, USD Million)
Table 9: French Market for AI in Medical Imaging by Modality (2023-2032, USD Million)
Table 10: French Market for AI in Medical Imaging by Revenue Stream (2023-2032, USD Million)
Table 11: French Market for AI in Medical Imaging by Clinical Application (2023-2032, USD Million)
Table 12: French Market for AI in Medical Imaging by End-Use Organization (2023-2032, USD Million)
Table 13: French Market for AI in Medical Imaging by AI Technology (2023-2032, USD Million)
Table 14: UK Market for AI in Medical Imaging by Clinical Area (2023-2032, USD Million)
Table 15: UK Market for AI in Medical Imaging by Modality (2023-2032, USD Million)
Table 16: UK Market for AI in Medical Imaging by Revenue Stream (2023-2032, USD Million)
Table 17: UK Market for AI in Medical Imaging by Clinical Application (2023-2032, USD Million)
Table 18: UK Market for AI in Medical Imaging by End-Use Organization (2023-2032, USD Million)
Table 19: UK Market for AI in Medical Imaging by AI Technology (2023-2032, USD Million)
Table 20: Italian Market for AI in Medical Imaging by Clinical Area (2023-2032, USD Million)
Table 21: Italian Market for AI in Medical Imaging by Modality (2023-2032, USD Million)
Table 22: Italian Market for AI in Medical Imaging by Revenue Stream (2023-2032, USD Million)
Table 23: Italian Market for AI in Medical Imaging by Clinical Application (2023-2032, USD Million)
Table 24: Italian Market for AI in Medical Imaging by End-Use Organization (2023-2032, USD Million)
Table 25: Italian Market for AI in Medical Imaging by AI Technology (2023-2032, USD Million)
Table 26: GTM Readiness Radar – Italy
Table 27: Spanish Market for AI in Medical Imaging by Clinical Area (2023-2032, USD Million)
Table 28: Spanish Market for AI in Medical Imaging by Modality (2023-2032, USD Million)
Table 29: Spanish Market for AI in Medical Imaging by Clinical Application (2023-2032, USD Million)
Table 30: Spanish Market for AI in Medical Imaging by Revenue Stream (2023-2032, USD Million)
Table 31: Spanish Market for AI in Medical Imaging by End-Use Organization (2023-2032, USD Million)
Table 32: Spanish Market for AI in Medical Imaging by AI Technology (2023-2032, USD Million)
Table 33: Rest of Europe Market for AI in Medical Imaging by Clinical Area (2023-2032, USD Million)
Table 34: Rest of Europe Market for AI in Medical Imaging by Modality (2023-2032, USD Million)
Table 35: Rest of Europe Market for AI in Medical Imaging by Revenue Stream (2023-2032, USD Million)
Table 36: Rest of Europe Market for AI in Medical Imaging by Clinical Application (2023-2032, USD Million)
Table 37: Rest of Europe Market for AI in Medical Imaging by End-Use Organization (2023-2032, USD Million)
Table 38: Rest of Europe Market for AI in Medical Imaging by AI Technology (2023-2032, USD Million)
Table 39: Adjacency-Opportunity Matrix – ROE (2026-2030)
Table 40: White-Space Partnership Matrix – ROE
List of Figures
Figure 1: Top-Down Market Funnel – Europe
Figure 2: Bottom-up Attach Rate Flow (Europe)
Figure 3: Evidence Confidence (Europe Moel) – Density vs Reliability
Figure 4: Regulatory Velocity by Company – Europe
Figure 5: Markintel Growth Maturity Matrix – Europe
Figure 6: Markintel™ Ecosystem Collaboration Matrix (ECM) – Europe
Figure 7: Markintel Solution Adoption & Growth Matrix – Europe
Figure 8: OEM AI Attach Rate – Europe (2024)
Figure 9: AI Revenue Split – Factory vs Retrofit Attach — Europe (2024)
Figure 10: GTM Readiness Radar — Europe
Figure 11: Potential by Customer Tier – Europe (2032)
Figure 12: GTM Timeline (2025 → 2028) – Europe
Figure 13: Adjacency Opportunity Radar (2026+) – Europe
Figure 14: Regulatory x Funding Heatmap – Europe (2024)
Figure 15: AI Imaging Whitespace Matrix – Europe
Figure 16: GTM Readiness Radar — Germany
Figure 17: Projected Imaging AI Spend by Customer Tier – Germany (2032)
Figure 18: GTM Timeline – Germany
Figure 19: GTM Readiness Radar — What Counts Most in France
Figure 20: GTM Timeline (2024 30) – France
Figure 21: Spend Potential by Customer Tier – France (2032)
Figure 22: GTM Readiness Radar – UK
Figure 23: Spend Potential by Customer Tier – UK (2032)
Figure 24: GTM Timeline (2024 29) – UK
Figure 25: Tiered Customer Landscape & Spend Potential (2032)
Figure 26: GTM Readiness Radar – Italy
Figure 27: GTM Timeline (2024-29) – Italy
Figure 28: GTM Readiness Radar – Spain
Figure 29: Tiered Customer Landscape – Spain
Figure 30: GTM Timeline – Spain (2024-2029)
Figure 31: GTM at a Glance – Rest of Europe (ROE)
Figure 32: Tiered Customer Landscape – ROE (2032)
Figure 33: GTM Timeline – ROE
Figure 34: Regulatory Funding Heatmap (ROE Clusters)
Driving healthcare innovation through actionable intelligence, strategic execution, and transformative solutions for global impact and growth.
